The Cuban COVID-19 candidate vaccine SOBERANA 02 entered phase III clinical trials in Havana to prove its efficacy.

The new coronavirus spreads out so fast and is so dangerous and unpredictable that there is no room for carelessness in surveillance or slowness in the application of health protocols. That is why this is a permanent battle and that is how the government is assessing the epidemiological situation in each province.

Cuban President Miguel Díaz-Canel Bermúdez highlighted today on his Twitter account the beginning of the third phase of clinical trials of Soberana 02, one of the five COVID-19 vaccine candidates developed in the country, thanked its creators, and praised the rigorous work of the Cuban Regulatory Authority, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED).

The Center for the State Control of Medicines, Equipment and Medical Devices (CECMED) approved the start of the Phase III Clinical Trial of Vaccine Candidate Soberana 02, from the Finlay Vaccine Institute.

Cuba has a fifth vaccine candidate against COVID-19, Soberana 01A, intended for convalescents of the disease, Cuban President Miguel Díaz-Canel Bermúdez reported today on his Twitter account after the creators of the vaccine (experts from the Finlay Vaccine Institute) confirmed the news at a weekly meeting of researchers.

HAVANA, Cuba, Mar 3 (ACN) The book La Psicología de la Salud en el enfrentamiento a la COVID-19 en América Latina is an initiative of the Latin American the Latin American Association of Health Psychology (ALAPSA).

"We are getting closer to the moment when we can safely vaccinate more people," Cuban President Miguel Díaz-Canel Bermúdez said at a meeting with the group of experts and scientists who for almost a year have been directly involved in Cuba's battle against the pandemic.

So far and in almost a year of outbreak of the SARS-CoV-2 virus, there have been no cases of reinfection with COVID-19 in Cuba, said today in Havana Dr. Francisco Duran Garcia, national director of epidemiology of the ministry of public health (MINSAP by its Spanish acronym).

Despite the restrictions imposed by the COVID-19, the kidney transplant program continues in the province of Camaguey (east of the country), where since 1978 580 surgeries of this type have been performed on patients from different Cuban territories.

Cuba will submit a new therapeutic candidate vaccine to trials on COVID-19 patients, starting April 1st.

Bruno Rodriguez Parrilla, Cuban foreign minister, highlighted today the highest scientific rigor with which the country's vaccine candidates against COVID-19 are being developed.

Some 160 Cuban health workers, who are part of the Henry Reeve Medical Contingent return on Monday from Mexico where they had been contributing to the fight against COVID-19.

Even if a significant number of people are vaccinated and covered with the Cuban vaccine, whose third phase of the clinical trial begins this month, the risk is really going to be present until immunity levels of 80 to 90 percent of our population are achieved.

Cuba studied 19,155 samples for COVID 19, resulting in 811 positive ones. The country accumulates 2,411,287 samples taken and 50,590 positive.